Factores de riesgo en población rural andina con COVID-19: un estudio de cohorte retrospectivo
Objective: To determine the risk factors in adults with COVID-19 in the rural Andean population during 2020. Methods: This multicenter retrospective cohort study included 184 adult patients (≥18 years) with COVID-19’s serological and molecular tests from three Hospitals in the Peruvian mountains (Ancash and Apurímac) included with clinical suspicion between April and June. Descriptive analysis and univariate logistic regression were used to explore the risk factors associated with patients with COVID-19.Results: Of total of patients, 14 (7.6%) had a SARS-CoV-2. In infected patients 12 (85.7%) were men with an average age of 47.3±21 years. Comorbidities were present in about a third of patients, with hypertension and diabetes being the most frequent (both 14.3%), and the most frequent symptoms were fever and hea-dache (57.2%). Univariate regression showed higher probabilities of infection with SARS-CoV-2 in the rural Andean population associated with advanced age (OR: 1.1 95% CI 0.7 - 1.8; p = 0.019), previous comorbidities (OR: 1.7, 95%CI 0.32 - 9.39; p = 0.006), and previous symptoms (OR: 49.8, 95%CI 5.6 - 436.9; p = 0.0011).Conclusions: Possible risk factors such as advanced age, comorbidities and previous symptoms are related to the development of COVID-19 in the rural Andean population of Peru..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Infectio - 25(2021), 4, Seite 256-261 |
| Sprache: |
Englisch ; Spanisch |
|---|
| Beteiligte Personen: |
Jeel Moya-Salazar [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Comorbidity |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
DOAJ012188522 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ012188522 | ||
| 003 | DE-627 | ||
| 005 | 20230307030507.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)DOAJ012188522 | ||
| 035 | |a (DE-599)DOAJd7f66de3be024e4aa2bc1acbcedd7fac | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a spa | ||
| 050 | 0 | |a RM1-950 | |
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Jeel Moya-Salazar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Factores de riesgo en población rural andina con COVID-19: un estudio de cohorte retrospectivo |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Objective: To determine the risk factors in adults with COVID-19 in the rural Andean population during 2020. Methods: This multicenter retrospective cohort study included 184 adult patients (≥18 years) with COVID-19’s serological and molecular tests from three Hospitals in the Peruvian mountains (Ancash and Apurímac) included with clinical suspicion between April and June. Descriptive analysis and univariate logistic regression were used to explore the risk factors associated with patients with COVID-19.Results: Of total of patients, 14 (7.6%) had a SARS-CoV-2. In infected patients 12 (85.7%) were men with an average age of 47.3±21 years. Comorbidities were present in about a third of patients, with hypertension and diabetes being the most frequent (both 14.3%), and the most frequent symptoms were fever and hea-dache (57.2%). Univariate regression showed higher probabilities of infection with SARS-CoV-2 in the rural Andean population associated with advanced age (OR: 1.1 95% CI 0.7 - 1.8; p = 0.019), previous comorbidities (OR: 1.7, 95%CI 0.32 - 9.39; p = 0.006), and previous symptoms (OR: 49.8, 95%CI 5.6 - 436.9; p = 0.0011).Conclusions: Possible risk factors such as advanced age, comorbidities and previous symptoms are related to the development of COVID-19 in the rural Andean population of Peru. | ||
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a risk factor | |
| 650 | 4 | |a mountains | |
| 650 | 4 | |a comorbidity | |
| 650 | 4 | |a sars-cov-2 | |
| 650 | 4 | |a peru. | |
| 653 | 0 | |a Therapeutics. Pharmacology | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 773 | 0 | 8 | |i In |t Infectio |d Asociación Colombiana de Infectología, 2018 |g 25(2021), 4, Seite 256-261 |w (DE-627)DOAJ000064378 |x 01239392 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2021 |g number:4 |g pages:256-261 |
| 856 | 4 | 0 | |u https://doi.org/10.22354/in.v25i4.957 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/d7f66de3be024e4aa2bc1acbcedd7fac |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0123-9392 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2021 |e 4 |h 256-261 | ||